Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CCR2 | P41597 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7505898 | 0.87 | ABCB11 (0.70) | ABCB11CCR2 | |
| SCHEMBL7679550 | 0.86 | MAPT (0.62) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7680923 | 0.84 | ABCB11 (0.65) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7681355 | 0.83 | MAPT (0.61) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7676152 | 0.82 | MAPT (0.58) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7508693 | 0.82 | MAPT (0.60) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7683084 | 0.80 | MAPT (0.61) | MAPTLMNAABCB11TP53CCR2 | |
| SCHEMBL7517302 | 0.79 | MAPT (0.80) | MAPTLMNAABCB11TP53SMN1; SMN2 | |
| SCHEMBL7682571 | 0.76 | ABCB11 (0.73) | ABCB11CCR2 | |
| SCHEMBL7701288 | 0.76 | MAPT (0.76) | MAPTLMNAABCB11TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056451-B1 | BICYCLIC PYRROLE DERIVATIVES AS MCP-1 INHIBITORS | ASTRAZENECA UK LTD (GB) | 2002-11-13 | — | — | EP | disclosed |
| US-6479527-B1 | Bicyclic pyrrole derivatives as MCP-1 inhibitors | ASTRAZENECA UK LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1056451-A1 | BICYCLIC PYRROLE DERIVATIVES AS MCP-1 INHIBITORS | AstraZeneca UK Limited (GB) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999040914-A1 | BICYCLIC PYRROLE DERIVATIVES AS MCP-1 INHIBITORS | ASTRAZENECA UK LIMITED (GB) | 1999-08-19 | — | — | WO | disclosed |